LH

NEUTRALEarnings

Labcorp Holdings Inc.

2026-11-02

Price

$355.59

+12.05%

This is the 2026-11-02 snapshot — the signals and analysis for LH as of this single trading day.

View full LH research hub →

Score1.6Noise

Signals3/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 9

Volume1.8xvs 20d avg

Analysis

Labcorp (LH) is undergoing High-Conviction Price Discovery driven by a stellar Q3 2026 earnings beat and raised full-year guidance. The fundamental strength—highlighted by 14.5% adjusted EPS growth and consistent margin expansion—perfectly aligns with its PERFECT_STACK and MARKET_LEADER technical signals, pushing the stock to new 52-week highs. Under the current CAUTION (EARNINGS) macro regime, where the SPY is lagging but internal breadth rewards quality, LH's +17.0% relative strength highlights aggressive institutional accumulation in a defensive-yet-growing healthcare name.

Fired Signals

GOLDEN CROSSMARKET LEADERPERFECT STACKWEAK FINISH

Key Takeaways

Actionable Thesis: LH is a high-conviction momentum play fueled by a fundamental Q3 earnings beat, raised FY26 guidance, and a PERFECT_STACK technical setup.
Key Risk: At 0.0% off its highs with 54.5% annualized volatility, the stock is extended and vulnerable to short-term profit-taking if broader market breadth suddenly deteriorates.
What to Watch: Monitor price action holding above the post-earnings gap and the $303.98 structural support level to confirm sustained institutional sponsorship.

← Back to 2026-11-02 View Full LH History →Yahoo Finance &nearr;